Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Head & Neck 1Endocrine 1CNS 1

Conditions

Thyroid Neoplasms 1Sarcoma 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Melanoma 1Kidney Neoplasms 1Hematologic Neoplasms 1Glioma 1Bone Neoplasms 1

Interventions

Filgrastim 10Ifosfamide 6Carboplatin 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Doxorubicin 4Cyclophosphamide 4pembrolizumab 3Thiotepa 3Temozolomide 3Etoposide 3Busulfan 3sargramostim 2ixabepilone 2fludarabine phosphate 2etoposide phosphate 2belinostat 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Paclitaxel 2Mycophenolic Acid 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Bortezomib 2Antilymphocyte Serum 2Amifostine 2tremelimumab 1seribantumab 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Genetic Testing × Sarcoma × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡